Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Gen Physiol Biophys ; 26(1): 48-55, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17579254

ABSTRACT

Our goal was to determine whether hyperinsulinaemic and diabetic state can affect vaso-depressor effects of insulin and pioglitazone (PIO), an insulin-sensitizing thiazolidinedione drug. For this purpose, we established an experimental type 2 diabetic model (streptozotocin-nicotinamide model) in adult male rats (DIA group) and some of them were treated with chronically high-dose insulin for 14 weeks (INS-T DIA group). Blood pressure, glucose, HbA(1C), triglyceride, cholesterol, plasma insulin levels and body weight were measured. Endothelium-denuded aortic rings were suspended in tissue baths for reactivity studies. Cumulative concentration-response curves of serotonin (5-hydroxytryptamine; 5-HT) were evaluated before and after 1 h incubations with insulin (10(-7) or 10(-4) U/l), or PIO (10 micromol/l) or insulin plus PIO. PIO or higher concentration of insulin (10(-4) U/l), each alone, attenuated 5-HT induced contractions in both groups of aortae. Vasodepressor effect of insulin was diminished by 12% +/- 4% in aortae from INS-T DIA group. The presence of PIO in the bath did not affect impaired vasodepressor response of insulin. Contractions induced by KCl, or Bay K 8644 were partly inhibited after PIO incubations, with similar E(max) and pD(2) values in both groups of aortae. The results indicate that PIO does not modulate directly vasodepressor effect of insulin in hyperinsulinaemic/diabetic state. But, the direct vasodepressor effect of PIO, partly by Ca(2+) channel inhibition, may be beneficial by improving insulin utilization due to increasing blood flow to the insulin-sensitive tissues in hyperinsulinaemic/diabetic state.


Subject(s)
Aorta/drug effects , Blood Pressure/drug effects , Diabetes Mellitus, Type 2/blood , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Thiazolidinediones/pharmacology , Vasoconstrictor Agents/pharmacology , Animals , Aorta/pathology , Aorta/physiology , Blood Pressure/physiology , Body Weight , Cholesterol/blood , Diabetes Mellitus, Experimental , Dose-Response Relationship, Drug , Glucose/metabolism , Insulin/blood , Male , Pioglitazone , Rats , Rats, Wistar , Serotonin/pharmacology , Time Factors , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...